Consolidation in the Generic Pharmaceutical Industry
An Evolving Landscape
For many years generic companies were the poor relations of the pharmaceutical industry, with modest growth rates and little or no transnational business operations. As generics companies have grown, often... |
Sawai Pharmaceutical Co., Ltd.-Therapeutic Competitors Report
Sawai Pharmaceutical Co., Ltd.-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Generic Drugs: World Market Outlook
22011-2021
How will the market for generic drugs perform from 2011? Visiongain's report shows you potential revenues to 2021. Find opportunities and prospects there.
The world generics market has great potential to... |
Japanese Generic Market Forecast to 2013
Generic drugs are produced and distributed without patent protection and marketed after the expiry date of patent or other rights. Usually, generic drugs are as effective as their master drugs... |
Partnering in the Global Generics Industry 2010
A guide to companies
"Facts, statistics and insights on 168 medium-sized generic manufacturers from 40 countriesThe operating environment for generics companies is changing rapidly as the industry matures and growth focuses on new market... |
Antibacterial Drugs: World Market Prospects
2012-2022
What are the commercial prospects for antibacterial treatments? Visiongain's report shows you potential revenue values to 2022. Find data, forecasts and discussions.
Discover sales predictions at world market, therapeutic class, product... |
Generics in Japan
Japan is the second largest pharmaceutical market in the world. But only 5% of the market, by value, is taken by generic drugs. Like other major industrialised nations... |
Japan Pharmaceuticals and Healthcare Report Q2 208
Japan's pharmaceutical market is currently valued at US$74.4bn and is easily the most mature in the Asia Pacific region. Top-line sales stagnated for the first time in 2006 and this... |
Japan Pharmaceuticals and Healthcare Report Q1
2012
BMI View: Japan's pharmaceutical market is proving to be a welcome refuge for the leading multinational drugmakers, which are experiencing austerity-induced revenue contractions in Western Europe and healthcare reform costs... |
Japan Pharmaceuticals and Healthcare Report
Q2 2011
In our latest regional Business Environment Ratings (BER) matrix, Japan remains the leading pharmaceutical market in the Asia Pacific, out of the 17 markets surveyed. Japan boasts a strong patented... |
Japan Pharmaceuticals and Healthcare Report Q3
2011
BMI View: Japan's pharmaceutical market is entering a period of low-single digit growth. Demand for medicines will be supported by an ageing population, a high prevalence of chronic diseases and... |
Generic Drugs: The Global Market--Focus on Asia
REPORT HIGHLIGHTS
THIS REPORT CONTAINS
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
Generic Drugs: The Global Market--Focus on Europe
REPORT HIGHLIGHTS
THIS REPORT CONTAINS:
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
Global Generics Guide: Part 2
Benchmarking country markets and strategic issue
Introduction
The generics market is undergoing significant change, with intense merger and acquisition activity, a raft of upcoming patent expiries and new legislation being enacted to promote generic prescription in the... |
Generic Pharmaceuticals Industry Report - Global
Business Performance Analysis
The Global Generic Pharmaceuticals Industry Report
This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals Industry Report. Using the unique Plimsoll method of analysis, each of the top... |
Generic Drugs: The Global Market--Focus on the Americas
REPORT HIGHLIGHTS
THIS REPORT CONTAINS:
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
Statins: The World Market
2011-2021
What will happen now in the statin drugs market?
What does the future hold for the statins industry and market? Our new report shows how the patent expiry of Lipitor and... |
Generic Drugs
The Global Market
REPORT HIGHLIGHTS
THIS REPORT CONTAINS:
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
